Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2008-03-18
2008-03-18
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001650, C424S009100, C424S009200, C549S388000
Reexamination Certificate
active
07344701
ABSTRACT:
The invention provides a novel class of xanthene dyes, some of which are functionalized to allow their coupling to conjugation partners of interest, e.g. biomolecules, drugs, toxins and the like. Also provided are conjugates of the dyes, methods of preparing and using the dyes and their conjugates and kits including the dyes and their conjugates.
REFERENCES:
patent: 4290955 (1981-09-01), Cincotta et al.
patent: 4647675 (1987-03-01), Mayer et al.
patent: 4935059 (1990-06-01), Mayer et al.
patent: 5610151 (1997-03-01), Glombik et al.
patent: 6399392 (2002-06-01), Haugland et al.
Maciej Adamczyk and Jonathan Grote, “Efficient Fluorescein Spirolactam and Bis-Spirolactam Synthesis”,Synthetic Communications, 31(17), 2681-2690, (2001).
Troy A. Walton, et al. “Evaluation of New Linkers and Synthetic Methods for Internal Modified Oligonucleotides”,Bioconjugate Chemistry, vol. 13, 1155-1158 (2002).
Lyttle Matt
Reddington Mark
Biosearch Technologies, Inc.
Jones Dameron L.
Morgan & Lewis & Bockius, LLP
LandOfFree
Xanthene dyes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthene dyes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthene dyes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2816097